Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auris Medical AgfiledCriticalAuris Medical Ag
Priority to ECSP088317priorityCriticalpatent/ECSP088317A/en
Publication of ECSP088317ApublicationCriticalpatent/ECSP088317A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención proporciona composiciones que contienen (i) un principio activo farmacéutico seleccionado de entre el grupo consistente en arilcicloalquilaminas o derivados, análogos o sales farmacéuticamente activas de las mismas, y (ii) un polímero biocompatible o una combinación de polímeros biocompatibles. Estas composiciones o los medicamentos que las contienen se pueden utilizar para la prevención y/o el tratamiento de enfermedades del oído interno, por ejemplo tinnitus.The present invention provides compositions containing (i) a pharmaceutical active ingredient selected from the group consisting of arylcycloalkylamines or pharmaceutically active derivatives, analogs or salts thereof, and (ii) a biocompatible polymer or a combination of biocompatible polymers. These compositions or the medications containing them can be used for the prevention and / or treatment of diseases of the inner ear, for example tinnitus.
ECSP0883172008-03-272008-03-27
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INTERNAL EAR DISORDERS
ECSP088317A
(en)
Pharmaceutical composition covered by a film comprising capecitabine and at least one disintegrant, useful in the treatment of cancer for patients who have difficulty swallowing oral solid dosage forms.
Isoquinolinone derivative, preparation method therefor, and pharmaceutical composition, comprising same as active ingredient, for prevention or treatment of poly(adp-ribose)polym erase-1 (parp-1)-associated disease.